Brief: Catalyst Pharmaceuticals Reports 98% Total Qtrly Revenue Growth Year-Over-Year

Catalyst Pharmaceuticals

10/05/2023 23:44

May 10 (Reuters) - Catalyst Pharmaceuticals Inc
 CPRX.O :
    * CATALYST PHARMACEUTICALS REPORTS RECORD FIRST QUARTER 2023
RESULTS, ACHIEVING 98% TOTAL REVENUE GROWTH YEAR-OVER-YEAR
    * CATALYST PHARMACEUTICALS - REPORTS RECORD TOTAL REVENUES
OF
$85.4 MILLION FOR Q1 2023
    * QTRLY GAAP EPS DILUTED OF $0.26 PER SHARE
    * QTRLY NON-GAAP EPS DILUTED OF $0.41 PER SHARE
    * AFFIRMS FULL YEAR TOTAL REVENUE GUIDANCE OF BETWEEN $375
MILLION
AND $385 MILLION
    * Q1 EARNINGS PER SHARE VIEW $0.32, REVENUE VIEW $81.6
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $381.5 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9DwvSw 
Further company coverage:  CPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))